Abstract:Hepatocellular carcinoma (HCC) is one of the deadliest cancers worldwide due to the lack of effective therapy methods. Therefore, there is an urgent need to develop novel therapies for HCC. CBL0137 is a small molecule that affects p53 and nuclear factor-kappa B (NF-κB). The expression of p53 was measured by using immunohistochemistry (IHC) in tumor and adjacent tissues. Western blotting (WB) and quantitative real-time polymerase chain reaction (qRT-PCR) were employed to detect the level of p-p53, p53, Bax, and PUMA after CBL0137 administration. CCK-8 and immunofluorescence staining (IF) assays were performed to evaluate the proliferation and viability of HCC cells. Flow cytometry was used to detect the apoptosis of HCC cells. Xenograft model was established to determine the effect of CBL0137 treatment on HCC tumor growth in vivo. HE staining was used to monitor HCC cell morphology and IHC staining for Ki-67 was performed to determine the tumor cell proliferation following CBL0137 treatment. Results showed that the expression of p-p53, p53, Bax, and PUMA was upregulated after CBL0137 administration. The viability, growth, and colony formation of HCC cells were significantly inhibited by CBL0137 in the CBL group compared with the NC group (p<0.05). Meanwhile, the results revealed that the proportions of apoptotic and necrotic cells were significantly elevated in the CBL group compared to the NC group (p<0.05). And the apoptosis-related proteins including PARP, caspase-3, caspase-7, caspase-8, and caspase-9 were increased in the CBL group compared with the NC group (p<0.05), while the NF-κB, p-NF-κB and p-AKT expression levels were significantly downregulated following CBL0137 treatment (p<0.05). Additionally, the tumor volume and weight were significantly reduced in the CBL group compared with the NC group (p<0.05). Moreover, HE staining and IHC staining for Ki-67 indicated that CBL0137 treatment could obviously induce cell apoptosis and suppress cell proliferation. CBL0137 treatment could effectively inhibit HCC cell proliferation and induce cell apoptosis associated with multiple factors expression.

Calcitriol Inhibits the Growth of MHCC97 Heptocellular Cell Lines by Down‐modulating C‐met and ERK Expressions

Calcitriol combined with lipiodol ultra-fluid inhibits the growth of MHCC97 hepatocellular carcinoma cell lines

Effects of Calcitriol and Its Analogues on Interaction of Mcp-1 and Monocyte-Derived Dendritic Cells in Vitro

Calcitriol Inhibits Cervical Cancer Cell Proliferation Through Downregulation of HCCR1 Expression

Effect of 1,25 dihydroxyvitamin D3 on the proliferation and epithelial-mesenchymal transition in cancer stem cells derived from anaplastic thyroid carcinoma

Investigating the Mechanisms of Anti-tumoral Effect of Combination Therapy of Calcitriol and Sodium Pentaborate Pentahydrate on HepG2 Hepatocellular Carcinoma Cells

Effects of vitamin D analogues EB1089 on proliferation, apoptosis and invasion of heptocellular cells

Calcitriol suppresses gastric cancer progression and cisplatin resistance by inhibiting glycolysis and M2 macrophage polarization through inhibition of mTOR activation

Calcitriol Promotes the Maturation of Hepatocyte-Like Cells Derived from Human Pluripotent Stem Cells.

A High Dose of Calcitriol Inhibits Glycolysis and M2 Macrophage Polarization in the Tumor Microenvironment by Repressing mTOR Activation: in vitro and Molecular Docking Studies

Calcitriol and Calcipotriol Modulate Transport Activity of ABC Transporters and Exhibit Selective Cytotoxicity in MRP1-overexpressing Cells

CBL0137 Administration Suppresses Human Hepatocellular Carcinoma Cells Proliferation and Induces Apoptosis Associated with Multiple Cell Death Related Proteins.

The mechanism of calcitriol in cancer prevention and treatment.

Role of Vitamin D Receptor in the Antiproliferative Effects of Calcitriol in Tumor-Derived Endothelial Cells and Tumor Angiogenesis In vivo

Cathelicidin Hcap18/ll-37 Promotes Cell Proliferation and Suppresses Antitumor Activity of 1,25(OH)2D3 in Hepatocellular Carcinoma.

Inhibition of Mouse Breast Tumor-Initiating Cells by Calcitriol and Dietary Vitamin D

Vitamin D3 Administration Induces Nuclear p27 Accumulation, Restores Differentiation, and Reduces Tumor Burden in a Mouse Model of Metastatic Follicular Thyroid Cancer

Effect of Calcipotriol on Proliferation and Apoptosis of Mouse Melanoma Cell Lines B16

Role of vitamin D3 in tumor aggressiveness and radiation response for hepatocellular carcinoma

C-Jun NH2-teminal Kinase 1 Interacts with Vitamin D Receptor and Affects Vitamin D-mediated Inhibition of Cancer Cell Proliferation.